Health

Chairman:  Joe Pitts (PA-16)
Jurisdiction: 
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Members

Republicans

Joe Pitts (PA), Chairman
Brett Guthrie (KY), Vice Chairman
Ed Whitfield (KY)
John Shimkus (IL)
Tim Murphy (PA)
Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Billy Long (MO)
Renee Ellmers (NC)
Larry Bucshon (IN)
Susan Brooks (IN)
Chris Collins (NY)
Joe Barton (TX)
Fred Upton (MI) (Ex Officio)

Democrats

Gene Green (TX), Ranking Member
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
G. K. Butterfield (NC)
Kathy Castor (FL)
John Sarbanes (MD)
Doris O. Matsui (CA)
Ben Ray Lujan (NM)
Kurt Schrader (OR)
Joseph P. Kennedy, III (MA)
Tony Cardenas (CA)
Frank Pallone, Jr. (NJ) (Ex Officio)

May 8, 2013 | Letter

To read a copy of the letter sent to the following state agencies, click here.

>>
May 8, 2013 | Press Release

WASHINGTON, DC – The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), today advanced legislation reauthorizing two important drug user fee programs for new and generic animal drugs and a bill to secure America’s prescription drug supply chain.

>>
May 7, 2013 | Press Release

WASHINGTON, DC – The House Energy and Commerce, Ways and Means, and Education and the Workforce Committees today released an updated version of the Obamacare Burden Tracker (#ObamacareBurden), which reveals the burden on employers and families has increased to a

>>
May 3, 2013 | Letter

Excerpt: We write in strong support of the Food and Drug Administration's (FDA) announcement to apply a "removed for safety or efficacy" determination to the crushabale form of OxyContin. This decision by FDA will help mitigate the harmful effects of the nation's prescription drug abuse crisis. inculding the suffering it causes in families across our country.

>>

Pages